ArticleKidney medicine2026
Dynamic Medication Challenges in Hemodialysis: Rethinking Medication Therapy Management Strategies Through Longitudinal Trends.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale & Objective: A pharmacist-led Hemodialysis-Medication Therapy Adherence Clinic mitigates drug-related problems (DRPs), yet its poorly understood trajectory keeps strategies reactive, limiting timely interventions. Longitudinal trends of DRP prevalence, characteristics, and associated factors of patients attending a Hemodialysis-Medication Therapy Adherence Clinic were explored. Study Design: Retrospective longitudinal cohort study. Setting & Participants: Complete records of adult patients undergoing maintenance HD who attended the Hemodialysis-Medication Therapy Adherence Clinic between January 2021 and August 2023 at a tertiary public hospital in Malaysia were included and examined. Exposure: Hemodialysis-Medication Therapy Adherence Clinic consisting of medication reconciliation, review and record, medication-related action plan, intervention, documentation, and follow-up. Outcomes: Longitudinal trends, characteristics, and predictive factors of DRPs. Analytical Approach: Prevalence was descriptively analyzed. Characteristics were classified using the Pharmaceutical Care Network Europe Association DRP Classification (v9.0), and predictive factors were determined using generalized linear mixed models. Results: A total of 76 patients' records involving 569 visits across 11 time points were included, with 546 DRPs identified. Longitudinal analysis showed high prevalence with periodic fluctuations, reaching the highest at visit 4 (n = 74, 13.6%) and lowest at visit 11 (n = 20, 3.7%). The DRP of suboptimal drug-treatment (P1.2) was the highest, followed by unnecessary drug-treatment (P3.2) in all visits, except in visit 7, where both categories were equally divided, whereas P3.2 predominated followed by P1.2 at visit 9. Patient-related factors, particularly nonadherence, were the primary causes across all visits except visit 9, where dose selection predominated. Multivariable analysis reported visit phase and anemia treatment had higher likelihood of clinically driven DRP, whereas longer hemodialysis duration and monitoring and administration-related issues reduced this likelihood. Limitations: This single-center retrospective study was limited by reduced generalizability and attrition over time. Conclusions: Identifying temporal patterns and predictors of DRPs can optimize Hemodialysis-Medication Therapy Adherence Clinic delivery. Future prospective multicentered research is warranted to increase generalizability and scalability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.